当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析 - 现金流量表

立方制药

(003020)

  

流通市值:29.86亿  总市值:41.35亿
流通股本:1.37亿   总股本:1.90亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金416,176,012.551,646,994,726.181,219,554,435.8886,897,488.23
  收到的税费返还6,837.0318,636,426.9218,754,208.6520,726
  收到其他与经营活动有关的现金18,062,88371,794,398.3962,164,969.8633,806,088.61
  经营活动现金流入小计434,245,732.581,737,425,551.491,300,473,614.31920,724,302.84
  购买商品、接受劳务支付的现金131,639,558.11499,001,575.37383,767,579.62320,484,856.11
  支付给职工以及为职工支付的现金62,463,470.64208,698,025.06158,566,262.36111,763,195.6
  支付的各项税费43,796,070.44187,201,861.82129,451,331.1188,496,714.36
  支付其他与经营活动有关的现金132,675,797.66629,638,871.54440,664,691.96303,377,068.78
  经营活动现金流出小计370,574,896.851,524,540,333.791,112,449,865.05824,121,834.85
  经营活动产生的现金流量净额63,670,835.73212,885,217.7188,023,749.2696,602,467.99
二、投资活动产生的现金流量:
  收回投资收到的现金160,000,000938,789,470.8598,377,416.01218,377,416.01
  取得投资收益收到的现金627,858.4724,522,190.1223,201,455.2422,171,581.68
  处置固定资产、无形资产和其他长期资产收回的现金净额1,779.758,004,480.761,721,995.4175,213.14
  收到的其他与投资活动有关的现金--25,300-
  投资活动现金流入小计160,629,638.22971,316,141.68623,326,166.66240,624,210.83
  购建固定资产、无形资产和其他长期资产支付的现金30,129,805.62118,456,422.4191,122,899.6265,219,814.88
  投资支付的现金330,000,000911,860,000611,860,000331,860,000
  投资活动现金流出小计360,129,805.621,030,316,422.41702,982,899.62397,079,814.88
  投资活动产生的现金流量净额-199,500,167.4-59,000,280.73-79,656,732.96-156,455,604.05
三、筹资活动产生的现金流量:
  吸收投资收到的现金-25,300--
  取得借款收到的现金10,000,000---
  收到其他与筹资活动有关的现金-1,140,521.75086,495
  筹资活动现金流入小计10,000,0001,165,821.75086,495
  分配股利、利润或偿付利息支付的现金406,471.11166,163,772.32125,760,565.92117,509,325.92
  支付其他与筹资活动有关的现金2,516,170.4514,628,271.8619,706,198.5211,753,465.16
  筹资活动现金流出小计2,922,641.56180,792,044.18145,466,764.44129,262,791.08
  筹资活动产生的现金流量净额7,077,358.44-179,626,222.43-145,466,764.44-129,176,296.08
四、汇率变动对现金及现金等价物的影响-79,524.7-59,152.46-23,824.49-7,247
五、现金及现金等价物净增加额-128,831,497.93-25,800,437.92-37,123,572.63-189,036,679.14
  加:期初现金及现金等价物余额413,893,621.67439,694,059.59439,694,059.59439,694,059.59
  期末现金及现金等价物余额285,062,123.74413,893,621.67402,570,486.96250,657,380.45
补充资料:
  净利润-163,551,446.54-91,530,260.09
  资产减值准备-11,469,964.79-9,495,304.44
  固定资产和投资性房地产折旧-74,837,921.3-36,557,769.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-74,837,921.3-36,557,769.15
  无形资产摊销-9,790,058.12-4,864,039.72
  长期待摊费用摊销-2,773,038.38-1,396,784.57
  处置固定资产、无形资产和其他长期资产的损失-1,677.88--1,769.91
  固定资产报废损失-652,887.92-1,372.76
  公允价值变动损失--149,013.75--141,882.36
  财务费用-2,398,963.88-1,408,492.45
  投资损失--27,718,188.08--26,123,630.38
  递延所得税--2,872,314.75--1,472,539.33
  其中:递延所得税资产减少--1,301,300.35--670,210.24
    递延所得税负债增加--1,571,014.4--802,329.09
  存货的减少-5,348,254.16--46,901,989.09
  经营性应收项目的减少--26,739,536.81-10,044,178.23
  经营性应付项目的增加--6,610,805.57-11,739,322.91
  其他-298,212.33-482,954.53
  融资租入固定资产-1,625,611.21--
  现金的期末余额-413,893,621.67-250,657,380.45
  减:现金的期初余额-439,694,059.59-439,694,059.59
  现金及现金等价物的净增加额--25,800,437.92--189,036,679.14
公告日期2026-04-282026-04-282025-10-302025-08-26
审计意见(境内)标准无保留意见
TOP↑